课题基金 / 基金详情

Phase III Clinical Trial to Evaluate Therapeutics for Genital Chlamydia Infection

Phase III Clinical Trial to Evaluate Therapeutics for Genital Chlamydia Infection
评估生殖器衣原体感染治疗方法的 III 期临床试验
批准号：
9147216
负责人：
EDWARD W. HOOK
金额：
$109.42万
依托单位：
UNIVERSITY OF ALABAMA AT BIRMINGHAM
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
项目状态：
已结题
起止时间：
2015-08-17 至 2017-08-16
来源：
https://reporter.nih.gov/project-details/9147216
关键词：
BiologicalChlamydia InfectionsClinical ResearchClinical TrialsClinical Trials Cooperative GroupGenital systemLaboratory PersonnelLeadershipPhase III Clinical TrialsResearch InfrastructureSexually Transmitted DiseasesTherapeuticTrainingclinical research siteexperienceprotocol developmentsample collectiontherapeutic evaluation

项目摘要

项目成果

EDWARD W. HOOK的其他基金

相似基金

相关文献

中文摘要
翻译
The Sexually Transmitted Infections Clinical Trials Group provides infrastructure to conduct sexually transmitted infections (STIs) related clinical research, including providing clinical sites, trained and experienced personnel, laboratories, protocol development, clinical trial coordination, biological sample collection, storage, scientific leadership, and other aspects related to the conduct of clinical studies.
英文摘要
The Sexually Transmitted Infections Clinical Trials Group provides infrastructure to conduct sexually transmitted infections (STIs) related clinical research, including providing clinical sites, trained and experienced personnel, laboratories, protocol development, clinical trial coordination, biological sample collection, storage, scientific leadership, and other aspects related to the conduct of clinical studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHASE II SAFETY AND EFFICACY STUDY OF A TREATMENT FOR VAGINITIS
海外基金